TacticScaleWhat Guangzhou Wondfo Biotech (万孚生物) Does & How It Makes Money (300482.SZ)
Updated October 2026 · reflects Guangzhou Wondfo Biotech's latest reported financials
Chinese maker of rapid diagnostic tests and point-of-care testing analyzers. It sells diagnostic test kits and reagents together with the analyzers that run them to hospitals, primary-care clinics, public health agencies, law enforcement and consumers in China and abroad.
How Guangzhou Wondfo Biotech makes money
It sells diagnostic test kits and reagents together with the analyzers that run them to hospitals, primary-care clinics, public health agencies, law enforcement and consumers in China and abroad. Ongoing sales of test kits used on its platforms likely provide repeat revenue.
What Guangzhou Wondfo Biotech does
Guangzhou Wondfo Biotech, founded in 1992 and based in Guangzhou, is an in vitro diagnostics (IVD) company that develops, manufactures and sells diagnostic products in China and internationally. It is best known for rapid test kits covering fertility, drugs of abuse, tumor markers, infectious and sexually transmitted diseases, and COVID-19. Over time it has built out a range of instrument platforms, including fluorescence immunoassay (such as the 16-channel Finecare FIA Meter X2), chemiluminescence, blood coagulation, blood gas and biochemistry, molecular diagnostics, pathology staining and HbA1c testing. Its products are used in clinical labs, critical care, chronic disease management, primary care, epidemic monitoring, disaster relief, on-site law enforcement and home health.
Products & services
- Rapid test kits (fertility, drug of abuse, infectious disease, COVID-19)
- Finecare FIA Meter X2 fluorescence immunoassay analyzer
- Chemiluminescence platform
- Blood coagulation and blood gas analyzers
- Molecular diagnostics platform
- HbA1c analyzer
万孚生物是做什么的？
广州万孚生物技术股份有限公司成立于1992年，总部位于广州，是一家体外诊断（IVD）企业，在国内外从事诊断产品的研发、生产和销售。公司以快速检测试剂闻名，覆盖生育、毒品、肿瘤标志物、传染病、性传播疾病及新冠等领域。 公司还布局了多个仪器平台，包括免疫荧光（如16通道Finecare FIA Meter X2）、化学发光、凝血、血气生化、分子诊断、病理染色和糖化血红蛋白检测等。产品用于临床检验、重症、慢病管理、基层医疗、疫情监测、灾害救援、现场执法和家庭健康管理等场景。
What is Guangzhou Wondfo Biotech worth?
On an owner-earnings DCF, Guangzhou Wondfo Biotech's most-likely value is about ¥17 versus a recent price near ¥16 (3% below fair value). But TacticScale only calls a stock undervalued when the price sits below its conservative no-growth floor (~¥9) with a margin of safety — so the honest verdict here is “Fairly priced — no edge.” Fair value earns its keep only at the extremes, not in the wide middle.
Price sits in the normal range — fair value isn't actionable here; it earns its keep only when price drops below the no-growth floor, or runs to roughly double the optimistic case.
Analysis, not advice. Fair value is a margin-of-safety estimate from a deterministic owner-earnings DCF, not a price target or recommendation. See the full breakdown →
Related companies
Beijing Hotgen Biotech (688068.SS) · Autobio Diagnostics (603658.SS) · Beijing Wandong Medical Technology (600055.SS) · Shenzhen New Industries Biomedical Engineering (300832.SZ) · QuidelOrtho (QDEL)